CTSA Program in Action
Through its network of research and community partners, the CTSA Program supports activities that address long-standing roadblocks in clinical and translational research to deliver health solutions faster.
CTSA In Action
Learn about CTSA Program activities and how they are making a difference in several priority research areas of emphasis.
Urgent Public Health Needs
COVID-19 Didn’t Drive Worse Outcomes for Babies in Neonatal Intensive Care Units
Babies admitted to neonatal intensive care units (NICUs) during the first 21 months of the COVID-19 pandemic were unlikely to be diagnosed with COVID-19. Moreover, those who were COVID positive did not experience higher rates of harmful effects and mortality than those without COVID-19. This is according to CTSA Program–supported researchers who studied data from more than 150,000 infants discharged from NICUs between January 2020 and September 2021.
Developing, Demonstrating and Disseminating Innovations That Turn Science into Medicine Faster
Machine Learning Reveals Rounder Hearts May Have Increased Risks
Having a healthy heart with a rounder left ventricle may put you at greater risk of such cardiac problems as cardiomyopathy, atrial fibrillation and heart failure. That’s according to CTSA Program researchers who used machine learning to study more than 38,000 images of people’s hearts.
Clinical Research Resources
Nationwide IRB Reliance Agreement Aimed at Speeding Research Reaches 1,000 Signatories
The Streamlined, Multisite, Accelerated Resources for Trials (SMART) Institutional Review Board (IRB) agreement has reached 1,000 participating sites, making it one of the largest medical research study reliance agreements in the United States.
Nurturing the Field of Translational Science
CTSA Program Supports Emerging Research on Health Effects of Plastics
An early-career investigator has developed techniques to study how chemicals used in medical devices affect the still-developing hearts of pediatric patients.